Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID06909409

D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis

Led by University of Aarhus · Updated on 2025-04-03

120

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying the role of human macrophages and vitamin D in people with Idiopathic Pulmonary Fibrosis (IPF). The study aims to understand whether patients with IPF have low vitamin D levels in their blood and lungs, and whether their lung macrophages promote fibrosis and inflammation. This observational research is sponsored by the University of Aarhus and focuses on gaining deeper insights into these factors in IPF and related lung diseases. Participants in this study include patients diagnosed with IPF, non-IPF interstitial lung disease, or lung cancer. There are no specific treatment interventions as this is an observational study. The study collects blood and bronchoalveolar lavage (BAL) samples to measure biomarker levels, vitamin D status, and analyze pulmonary macrophages at enrollment. During the study, participants undergo assessments at enrollment to evaluate vitamin D levels and lung macrophage characteristics. Blood and BAL samples are collected for biomarker analysis. The study seeks to better understand disease mechanisms by comparing these measures across different lung conditions. Participation involves providing informed consent and attending study visits for sample collection and assessments. The study started in October 2024 and will continue until October 2026.

CONDITIONS

Brief Title

D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • A clinical diagnosis of IPF, non-IPF ILD or lung cancer
  • A signed informed consent
Not Eligible

You will not qualify if you...

  • Do not speak Danish/Do not understand Danish

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Day of enrollment

Participants undergo assessments including measurement of Vitamin D status and pulmonary macrophages at enrollment.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 5 years

Participants are observed over time to monitor biomarker levels and disease status without active intervention.

Visits as per routine clinical care

Trial Site Locations

Total: 1 location

1

Aarhus University Hospital, Denmark

Aarhus N, Denmark, 8200

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

Adaptive, Randomised, Double-blind, Placebo-controlled Trial...

Idiopathic Pulmonary Fibrosis (IPF)

Actively Recruiting

1 location

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Stud...

Idiopathic Pulmonary Fibrosis (IPF)

Actively Recruiting

16 locations

A Pilot Study to Assess Body Mass Composition Using Bioimped...

Idiopathic Pulmonary Fibrosis (IPF)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here